Daily FNArena News - Small Caps

All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest

Previous Stories

Asia Embraces Algae.Tec

Dec 05 2011

As Algae.Tec’s carbon capture and biofuel production technology moves towards production at its Australian showcase facility, a Sri Lankan company has signed Algae.Tec’s first commercial deal in Asia.


Several Reasons To Like Bathurst Resources

Dec 05 2011

While permit approvals offer some risk, high quality output and M&A potential lead Citi to initiate coverage on coal junior Bathurst Resources with a Buy rating.


Is Retail Food Group Undervalued?

Dec 02 2011

An attractive franchise model and a resilient category should support earnings for Retail Food Group, reports UBS.


Fiji Project Makes Amex Resources A Buy

Nov 25 2011

Amex Resources is developing the Mba Delta Iron sand project in Fiji and DJ Carmichael initiates with a Buy rating, seeing significant upside potential as the project moves towards production.


US Potential Makes Breville A Buy

Nov 11 2011

Subdued domestic operating conditions don’t detract from the value on offer in Breville according to Moelis.


Prima Biomed And The Topic Of Cancer

Nov 10 2011

Nomura has initiated coverage on Prima Biomed with a Buy rating, attracted to the group’s potential to develop an immunotherapy-based treatment for ovarian cancer.


Ampella Attracting Interest

Oct 27 2011

With RBS Australia initiating coverage on Apella Mining it brings to three the number of brokers researching the gold junior, all of which rate the company as a Buy.


Neuren Pharma Could Be The Only One

Oct 21 2011

The lead compound of Neuren Pharmaceuticals is being developed to treat brain injuries and with no current competition in the market Bell Potter sees upside from any success.


Neptune Marine – A Turnaround Story

Oct 20 2011

DJ Carmichael has initiated coverage on Neptune Marine with a Spec Buy rating, viewing the stock as a turnaround story as new management grows a restructured business.


Significant Upside Potential For GI Dynamics

Oct 19 2011

GI Dynamics is developing the EndoBarrier product for use in treating type II diabetes and obesity and Bell Potter sees significant upside potential in the stock.



Analyse The Market From A Different Angle